Surgical management of high-risk, localized prostate cancer | Nature Reviews Urology
Current Oncology | Free Full-Text | Triplet Therapy in Metastatic Castrate Sensitive Prostate Cancer (mCSPC)—A Potential New Standard of Care
Untreated Metastatic Prostate Cancer - 2021 Prostate Cancer Patient Conference - YouTube
Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer | Journal of
Oligometastatic Prostate Cancer – Treatment of the Primary Tumor and Metastasis Directed Therapy
![Definition of high and low volume, and risk in CHAARTED [54-56] and... | Download Scientific Diagram](https://www.researchgate.net/profile/Thomas-Lam-3/publication/344701128/figure/tbl1/AS:947382543978497@1602885008589/Definition-of-high-and-low-volume-and-risk-in-CHAARTED-54-56-and-LATITIDE-57-based.png "Definition of high and low volume, and risk in CHAARTED [54-56] and... | Download Scientific Diagram")
Definition of high and low volume, and risk in CHAARTED [54-56] and... | Download Scientific Diagram
Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? - The Lancet Oncology
ASCO GU 2020: Targeted Therapy in the Context of Low Volume Metastatic Prostate Cancer
Prognostic Value of the LATITUDE and CHAARTED Risk Criteria for Predicting the Survival of Men with Bone Metastatic Hormone-Naïve Prostate Cancer Treated with Combined Androgen Blockade Therapy: Real-World Data from a Japanese
Oligometastatic Prostate Cancer: A Shrinking Subset or an Opportunity for Cure? | American Society of Clinical Oncology Educational Book
Computed Tomography (CT) and Bone Scans (BS) for Hormone Sensitive Prostate Cancer - YouTube
Prostate | Radiology Key
Triplet Therapy Has a Place in Metastatic Hormone-Sensitive Prostate Cancer Treatment, But For Whom?
![Definition of high and low volume, and risk in CHAARTED [54-56] and... | Download Scientific Diagram](https://www.researchgate.net/profile/Thomas-Lam-3/publication/344701128/figure/tbl2/AS:947382543974400@1602885008617/Key-findings-hormonal-treatment-combined-with-chemotherapy-in-men-presenting-with_Q320.jpg "Definition of high and low volume, and risk in CHAARTED [54-56] and... | Download Scientific Diagram")
Definition of high and low volume, and risk in CHAARTED [54-56] and... | Download Scientific Diagram
EAU 2018: Variation in Prevalence of High and Low Volume Metastatic Prostate Cancer from the Original Comparison in the STAMPEDE Trial
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial - The Lancet
Page 47 - PACE: Advanced Prostate Cancer Consensus
APCCC 2019: Synthesis - Optimal Treatment of Men with Newly Diagnosed Prostate Cancer
ASCO 2023: Prostate Irradiation in Men with De Novo, Low-Volume, Metastatic, Castration-Sensitive Prostate Cancer (mCSPC): Results of PEACE-1, a Phase 3 Randomized Trial with a 2x2 Design
September 15, 2014 - What Constitutes High-Volume/Extensive Disease? - The ASCO Post
Metastatic Prostate Cancer: Sorting Through the Treatment Maze - The ASCO Post
EAU 2018: Variation in Prevalence of High and Low Volume Metastatic Prostate Cancer from the Original Comparison in the STAMPEDE Trial
Overall Survival After Systemic Treatment in High-volume Versus Low-volume Metastatic Hormone-sensitive Prostate Cancer: Systematic Review and Network Meta-analysis - European Urology Focus
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer | Swiss Medical Weekly
Stratification of prostate cancer based on tumor volume and Gleason... | Download Scientific Diagram
ASCO GU 2020: Targeted Therapy in the Context of Low Volume Metastatic Prostate Cancer
